Global Electronic Clinical Outcome Assessment (eCOA) Solutions Market Size study, by Product (Web Based Solutions, on Premise Solutions, Cloud Based Solutions), Approach (PRO, CLINRO, OBSRO, Perfo), End User (Pharmaceutical and Biopharmaceutical Companies

Global Electronic Clinical Outcome Assessment (eCOA) Solutions Market Size study, by Product (Web Based Solutions, on Premise Solutions, Cloud Based Solutions), Approach (PRO, CLINRO, OBSRO, Perfo), End User (Pharmaceutical and Biopharmaceutical Companies, Contract Research Organizations, Medical Device Manufacturers, Hospitals and Clinical Laboratories)and Regional Forecasts 2022-2028

Global Electronic Clinical Outcome Assessment (eCOA) Solutions Market is valued approximately USD 1.2 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 14% over the forecast period 2022-2028.Clinical trials collect patient data using an eCOA solution. During the forecast period, the global market for electronic clinical outcome assessment (eCOA) solutions is expected to grow at a steady pace. Increased regulatory compliance among industrial researchers, growing public-private investments in clinical research, a growing need for improved data standardization and collection aimed at early regulatory approval, and an expanding end user base across major countries are among the major factors driving their market expansion. For instance, OmniComm Systems Inc. and Kayentispartnered in June 2018. Under the terms of the agreement, the two companies will collaborate to provide life science clients with OmniComm'sTrialMaster electronic data capture (EDC) suite integrated with Kayentis' Clin'form, eCOA solution Suite, resulting in improved platform integration.Furthermore, during the study period, an increase in clinical research in emerging countries, as well as increased research outsourcing by pharma behemoths and an industry shift from manual data interpretation to real-time data analysis, are expected to provide significant growth opportunities for global players. However, significant implementation costs and a scarcity of well-skilled professionals from accurate data interpretation are expected to limit their optimal demand growth during the forecast period,.



The key regions considered for the global Electronic Clinical Outcome Assessment (eCOA) Solutions Marketstudy includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America holds the largest regional market. In the coming years, the presence of technologically advanced research centres, medical device manufacturers, universities, and hospitals, as well as improved healthcare establishments, is expected to drive new drug development activities. Due to higher adoption levels of eClinical solutions, the United States held the largest market share in North America. In the coming years, initiatives involving the adoption of eClinical platforms by key end users are expected to increase usage. Whereas, Asia Pacific is expanding in terms of patient pool, outsourcing, and MNC and CRO investment in clinical research and drug discovery. This is expected to boost market growth. Clinical research outsourcing is primarily done in India and China for major pharmaceutical and biotech companies. Over the forecast period, this is expected to be a major contributor to the growing demand for eCOA solutions.

Major market player included in this report are:
IBM
IQVIA Inc.
Medidata Solutions, Inc.
Clario
ArisGlobal
Signant Health
TransPerfect
Cloudbyz
Climedo Health GmbH
ClinCapture
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
ByDelivery Mode:
On-premise
Web & Cloud-based

By End-User:
Hospitals/Healthcare providers
CROs

Pharmaceutical and Biotechnology Firms
Medical Device Companies
Others

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Electronic Clinical Outcome Assessment (eCOA) Solutions Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Companies Mentioned

IBM
IQVIA Inc.
Medidata Solutions, Inc.
Clario
ArisGlobal
Signant Health
TransPerfect
Cloudbyz
Climedo Health GmbH
ClinCapture

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.